Understanding the Onset of Asthma and Strategies to Reduce Its Risk
DOI:
https://doi.org/10.55544/jrasb.5.1.28Keywords:
Asthma, inflammation, environment, chemical pollutants, air quality, external contaminantsAbstract
The symptoms of asthma, a long-term respiratory condition marked by inflammation and airway narrowing, include wheezing, coughing, tightness in the chest, and shortness of breath. Due to a number of lifestyle and environmental variables, the prevalence of asthma has dramatically increased globally in recent decades. Genetic vulnerability and environmental exposures, such as air pollution, allergens, tobacco smoke, and occupational irritants, all have a role in the development of asthma. Particularly in children and vulnerable groups, ongoing exposure to particulate matter, dust mites, pollen, and chemical pollutants can cause airway inflammation and hypersensitivity, which can result in the development of asthma.
This study examines the main causes of asthma onset and emphasizes doable tactics to lower the risk. Important preventive strategies include ensuring adequate ventilation, lowering exposure to external contaminants, improving indoor air quality, and implementing healthy lifestyle choices. Reducing the occurrence of asthma can also be greatly aided by raising public awareness and identifying triggers early. Improving respiratory health and lowering the prevalence of asthma worldwide can be greatly aided by comprehending the mechanisms underlying asthma development and putting effective preventative measures into practice.
Downloads
References
[1] Global Asthma Network. (2018). The global asthma report 2018.
[2] 2.Bateman, E. D., Hurd, S. S., Barnes, P. J., et al. (2008). Global strategy for asthma management and prevention: GINA executive summary. European Respiratory Journal, 31, 143–178.
[3] Bousquet, J., Jeffery, P. K., Busse, W. W., et al. (2000). Asthma: From bronchoconstriction to airways inflammation and remodeling. American Journal of Respiratory and Critical Care Medicine, 161, 1720–1745.
[4] 4.Fehrenbach, H., Wagner, C., & Wegmann, M. (2017). Airway remodeling in asthma: What really matters. Cell and Tissue Research, 367, 551–569.
[5] 5. Tang, M. L., Wilson, J. W., Stewart, A. G., et al. (2006). Airway remodelling in asthma: Current understanding and implications for future therapies. Pharmacology & Therapeutics, 112, 474–488.
[6] 6.Carpaij, O. A., Nieuwenhuis, M. A., Koppelman, G. H., et al. (2017). Childhood factors associated with complete and clinical asthma remission at 25 and 49 years. European Respiratory Journal, 49, 1601974.
[7] 7. Vonk, J., Postma, D., Boezen, H., et al. (2004). Childhood factors associated with asthma remission after 30-year follow-up. Thorax, 59, 925–929.
[8] 8. Menzies-Gow, A., Bafadhel, M., Busse, W. W., et al. (2020). An expert consensus framework for asthma remission as a treatment goal. Journal of Allergy and Clinical Immunology, 145, 757–765.
[9] 9. Menzies-Gow, A., Szefler, S. J., & Busse, W. W. (2021). The relationship of asthma biologics to remission for asthma. Journal of Allergy and Clinical Immunology: In Practice, 9, 1090–1098.
[10] 10. Upham, J. W., & James, A. L. (2011). Remission of asthma: The next therapeutic frontier? Pharmacology & Therapeutics, 130, 38–45.
[11] 11. Carpaij, O. A., Burgess, J. K., Kerstjens, H. A., et al. (2019). A review on the pathophysiology of asthma remission. Pharmacology & Therapeutics, 201, 8–24.
[12] 12. Thomas, D., McDonald, V. M., & Pavord, I. D. (2022). Asthma remission: what is it and how can it be achieved? European Respiratory Journal, 60(5), 2102583.
[13] 13.Litonjua, A. A., Carey, V. J., Burge, H. A., et al. (1998). Parental history and the risk for childhood asthma: Does mother confer more risk than father? American Journal of Respiratory and Critical Care Medicine, 158, 176–181.
[14] 14.Stikker, B. S., Hendriks, R. W., & Stadhouders, R. (2023). Decoding the genetic and epigenetic basis of asthma. Allergy, 78, 940–956.
[15] 15. Lambrecht, B. N., Ahmed, E., & Hammad, H. (2025). The immunology of asthma. Nature Immunology, 26, 1233–1245.
[16] 16. A, Mouthuy, J., Durham, S. R., et al. (2016). Asthma phenotypes and IgE responses. European Respiratory Journal, 47, 304–319.
[17] 17.Camiolo, M. J., Kale, S. L., Oriss, T. B., et al. (2021). Immune responses and exacerbations in severe asthma. Current Opinion in Immunology, 72, 34–42.
[18] 18.Holgate, S. T. (2012). Innate and adaptive immune responses in asthma. Nature Medicine, 18, 673–683.
[19] 19. Horvat, J. C., Kim, R. Y., Weaver, N., et al. (2023). Characterization and inhibition of inflammasome responses in severe and non-severe asthma. Respiratory Research, 24, 303.
[20] 20. Heijink, I. H., Kuchibhotla, V. N. S., Roffel, M. P., et al. (2020). Epithelial cell dysfunction, a major driver of asthma development. Allergy, 75, 1902–1917.
[21] 21.An, S. S., Bai, T. R., Bates, J. H. T., et al. (2007). Airway smooth muscle dynamics: A common pathway of airway obstruction in asthma. European Respiratory Journal, 29, 834–860.
[22] 22.Valverde-Molina, J., & García-Marcos, L. (2023). Microbiome and asthma: Microbial dysbiosis and the origins, phenotypes, persistence, and severity of asthma. Nutrients, 15, 486.
[23] 23.Hufnagl, K., Pali-Schöll, I., Roth-Walter, F., & Jensen-Jarolim, E. (2020). Dysbiosis of the gut and lung microbiome has a role in asthma. Seminars in Immunopathology, 42, 75–93.
[24] 24.Gao, Y., Nanan, R., Macia, L., et al. (2021). The maternal gut microbiome during pregnancy and offspring allergy and asthma. Journal of Allergy and Clinical Immunology, 148, 669–678.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Dr. Meenakshi Yadav
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
10.55544/jrasb
editor@jrasb.com or mailtojrasb@gmail.com | 
+91-8874396939
This work is licensed under a 